MBOT Stock Analysis: Buy, Sell, or Hold?
MBOT - Microbot Medical, Inc. Common Stock
$1.44
-0.02 (-1.37%)
▼
5d:
-4.0%
30d:
-22.16%
90d:
-26.53%
HOLD
LOW Confidence
Analysis Updated: Sep 3, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When MBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MBOT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MBOT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: MBOT is currently trading at $1.44, which is considered oversold relative to its 30-day fair value range of $1.48 to $1.77. From a valuation perspective, the stock is trading at a discount (Forward PE: -4.2) compared to its historical average (18.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MBOT is in a strong downtrend. The price is currently testing key support at $1.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MBOT scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.67 (+363.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MBOT is in a strong downtrend. The price is currently testing key support at $1.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MBOT scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.67 (+363.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.48 -
$1.77
Company Quality Score
71/100
(BUY)
Options IV Signal
27th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
96.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 27th percentile)
- BULLISH: Strong technical setup (92/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 363.0% below Wall St target ($6.67)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 17% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.48 -
$1.77
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.14
(9.8%)
Support & Resistance Levels
Support Level
$1.44
Resistance Level
$1.57
Current Trend
Strong Downtrend
Technical data as of
Sep 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.19
Wall Street Target
$6.67
(+363.0%)
PE vs Historical
-4.2 vs 18.5
CHEAP
Share & Embed Analysis
Last updated: September 04, 2026 8:27 AM ET
Data refreshes hourly during market hours. Next update: 9:27 AM
Data refreshes hourly during market hours. Next update: 9:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 45 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 55 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 43 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 54 HOLD |
